Mitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders

Bibliography

• Aronson JK. editor. Meyler’s side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. 15th edition. Karger Science; Oslo, Norway; 2006
   Google Scholar
• Voigt N, Heijman J, Dobrev D. Cardiovascular pharmacotherapy. Risks and adverse effects. Herz 2014;39:227-38
   PubMed Web of Science ®Google Scholar
• Finsterer J, Ohnsorge P. Influence of mitochondrion-toxic agents on the cardiovascular system. Regul Toxicol Pharmacol 2013;67:434-45
   PubMed Web of Science ®Google Scholar
• Münzel T. Recent findings on nitrates: their action, bioactivation and development of tolerance. Dtsch Med Wochenschr 2008;133:2277-82
   PubMed Web of Science ®Google Scholar
• Chen CH, Ferreira JC, Gross ER, et al. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 2014;94:1-34
   PubMed Web of Science ®Google Scholar
• Esplugues JV, Rocha M, Nunez C, et al. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 2006;99:1067-75
   PubMed Web of Science ®Google Scholar
• Xiong Y, Singh IN, Hall ED. Tempol protection of spinal cord mitochondria from peroxynitrite-induced oxidative damage. Free Radic Res 2009;43:604-12
   PubMed Web of Science ®Google Scholar
• Blanco Garcia J, Aldinucci C, Maiorca SM, et al. Physiopathological effects of the NO donor 3-morpholinosydnonimine on rat cortical synaptosomes. Neurochem Res 2009;34:931-41
   PubMed Web of Science ®Google Scholar
• Singh IN, Sullivan PG, Hall ED. Peroxynitrite-mediated oxidative damage to brain mitochondria: protective effects of peroxynitrite scavengers. J Neurosci Res 2007;85:2216-23
   PubMed Web of Science ®Google Scholar
• Philips B, Madhavan S, James C, et al. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:160-6
   PubMed Web of Science ®Google Scholar
• Prince PS, Sathya B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur J Pharmacol 2010;635:142-8
   PubMed Web of Science ®Google Scholar
• Lu F, Xing J, Zhang X, et al. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem 2013;381:41-50
   PubMed Web of Science ®Google Scholar
• Sahu BD, Putcha UK, Kuncha M, et al. Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice. Mol Cell Biochem 2014; In press
   Web of Science ®Google Scholar
• Kahn MG. Cardiac drug therapy. Humana Press, Totowa, NJ; 2007
   Google Scholar
• Agarwal AK, Rao SS. Effect of quinidine on kidney biochemistry and function in male Sprague-Dawley rats. Food Chem Toxicol 1995;33:203-7
   PubMed Web of Science ®Google Scholar
• Bachmann E, Weber E, Zbinden G. Biochemical mechanisms of quinidine cardiotoxicity. J Cardiovasc Pharmacol 1986;8:826-31
   PubMed Web of Science ®Google Scholar
• Kawasaki C, Kawasaki T, Ogata M, et al. Lidocaine enhances apoptosis and suppresses mitochondrial functions of human neutrophil in vitro. J Trauma 2010;68:401-8
   PubMed Web of Science ®Google Scholar
• Vargas F, Vargas P, Aoki K, et al. In vivo and in vitro effects of phenytoin (PHT) on ATPases and [14C]-PHT binding in synaptosomes and mitochondria from rat cerebral cortex. Epilepsia 1994;35:882-8
   PubMed Web of Science ®Google Scholar
• Dzimiri N. Effects of procainamide, tocainide and phenytoin on guinea pig cardiac mitochondrial ATPase activity. Res Commun Chem Pathol Pharmacol 1993;80:121-4
   PubMedGoogle Scholar
• Abramov JP, Wells PG. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice. FASEB J 2011;25:2188-200
   PubMed Web of Science ®Google Scholar
• Santos NA, Medina WS, Martins NM, et al. Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 2008;22:1143-52
   PubMed Web of Science ®Google Scholar
• Chiyonobu T, Noda R, Yoshida M, et al. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev 2008;30:430-3
   PubMed Web of Science ®Google Scholar
• de Saint Jean M, Debbasch C, Brignole F, et al. Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells. J Fr Ophtalmol 2000;23:111-21
   PubMed Web of Science ®Google Scholar
• Debbasch C, Pisella PJ, De Saint Jean M, et al. Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001;42:2525-33
   PubMed Web of Science ®Google Scholar
• Oliveira PJ, Santos DJ, Moreno AJ. Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria. Arch Biochem Biophys 2000;374:279-85
   PubMed Web of Science ®Google Scholar
• Sgobbo P, Pacelli C, Grattagliano I, et al. Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2-mediated oxidative insult in H9C2 myocardial cells. Biochim Biophys Acta 2007;1767:222-32
   PubMed Web of Science ®Google Scholar
• Oliveira PJ, Bjork JA, Santos MS, et al. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 2004;200:159-68
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang J, Xu Y, et al. Effect of carvedilol on cardiomyocytes apoptosis in a rat model of myocardial infarction: a role for toll-like receptor 4. Indian J Pharmacol 2013;45:458-63
   PubMed Web of Science ®Google Scholar
• Serviddio G, Bellanti F, Giudetti AM, et al. Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. Free Radic Biol Med 2011;51:2234-42
   PubMed Web of Science ®Google Scholar
• Waldhauser KM, Török M, Ha HR, et al. Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 2006;319:1413-23
   PubMed Web of Science ®Google Scholar
• Cho YS, Han JH, Chae HB, et al. A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism. Korean J Gastroenterol 2013;62:59-63
   PubMedGoogle Scholar
• Felser A, Stoller A, Morand R, et al. Hepatic toxicity of dronedarone in mice: role of mitochondrial beta-oxidation. Toxicology 2014;323C:1-9
   Google Scholar
• Felser A, Blum K, Lindinger PW, et al. Mechanisms of hepatocellular toxicity associated with dronedarone – a comparison to amiodarone. Toxicol Sci 2013;131:480-90
   PubMed Web of Science ®Google Scholar
• Yu Q, Xiao C, Zhang K, et al. The calcium channel blocker verapamil inhibits oxidative stress response in Candida albicans. Mycopathologia 2014;177:167-77
   PubMed Web of Science ®Google Scholar
• Salabei JK, Balakumaran A, Frey JC, et al. Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicol Appl Pharmacol 2012;262:265-72
   PubMed Web of Science ®Google Scholar
• Liu N, Huang H, Liu S, et al. Calcium channel blocker verapamil accelerates gambogic acid-induced cytotoxicity via enhancing proteasome inhibition and ROS generation. Toxicol In Vitro 2014;28:419-25
   PubMed Web of Science ®Google Scholar
• Morakinyo A, Iranloye B, Adegoke O. Calcium antagonists modulate oxidative stress and acrosomal reaction in rat spermatozoa. Arch Med Sci 2011;7:613-18
   PubMed Web of Science ®Google Scholar
• Fox RM, Morgan RM, Markham A. Calcium antagonists and Bay K8644 promote depolarization of the rat heart mitochondrial membrane potential. Further evidence for a role in alteration of oxidative metabolism. Biochem Pharmacol 1993;45:1995-2001
   PubMed Web of Science ®Google Scholar
• Tabouy L, Chauvet-Monges AM, Salducci MD, et al. Protective effect of some calcium antagonists against mitochondrial calcium injury. Int J Tissue React 1994;16:221-8
   PubMedGoogle Scholar
• Crenesse D, Tornieri K, Laurens M, et al. Diltiazem reduces apoptosis in rat hepatocytes subjected to warm hypoxia-reoxygenation. Pharmacology 2002;65:87-95
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang J, Zhang Q, et al. Adenosine induces apoptosis in human liver cancer cells through ROS production and mitochondrial dysfunction. Biochem Biophys Res Commun 2014;448:8-14
   PubMed Web of Science ®Google Scholar
• Valdez LB, Zaobornyj T, Bombicino S, et al. Complex I syndrome in myocardial stunning and the effect of adenosine. Free Radic Biol Med 2011;51:1203-12
   PubMed Web of Science ®Google Scholar
• Ramirez-Ortega M, Zarco G, Maldonado V, et al. Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis? Eur J Pharmacol 2007;566:34-42
   PubMed Web of Science ®Google Scholar
• Alonso E, Cano-Abad MF, Moreno-Ortega AJ, et al. Nanomolar quabain elicits apoptosis through a direct action on HeLa cell mitochondria. Steroids 2013;78:1110-18
   PubMed Web of Science ®Google Scholar
• Campia I, Sala V, Kopecka J, et al. Digoxin and quabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes. Biochem J 2012;447:301-11
   PubMed Web of Science ®Google Scholar
• Tsyganĭ AA, Medvinskaia NA, Rudenko AF. Effect of digoxin, strophanthin and isolanid on oxygen absorption, oxidative phosphorylation and the amount of cytochromes in the myocardial mitochondria and their ATPase activity. Farmakol Toksikol 1982;45:30-2
   Google Scholar
• Tanz RD, Russell NJ. Mechanism of cardiac glycoside-induced toxicity: physiology, biochemistry, and electron microscopy. Fed Proc 1983;42:2470-4
   PubMedGoogle Scholar
• Khatter JC, Agbanyo M, Navaratnam S, et al. Digitalis cardiotoxicity: cellular calcium overload a possible mechanism. Basic Res Cardiol 1989;84:553-63
   PubMed Web of Science ®Google Scholar
• Ghazi-Khansari M, Mohammadi-Bardbori A, Hosseini MJ. Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (thiol and nonthiol ACEi). Ann N Y Acad Sci 2006;1090:98-107
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Boraso A, Scotti C, et al. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium. J Mol Cell Cardiol 1994;26:69-86
   PubMed Web of Science ®Google Scholar
• Small WJr, Molteni A, Kim YT, et al. Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper. Breast Cancer Res Treat 1999;55:223-9
   PubMed Web of Science ®Google Scholar
• Loffing J, Loffing-Cueni D, Hegyi I, et al. Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int 1996;50:1180-90
   PubMed Web of Science ®Google Scholar
• Chiusa M, Timolati F, Perriard JC, et al. Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity. Eur J Histochem 2012;56:e15
   PubMed Web of Science ®Google Scholar
• Chatterjee SS, Stefanovich V. Influence of anti-inflammatory agents on rat liver mitochondrial ATPase. Arzneimittelforschung 1976;26:499-502
   PubMed Web of Science ®Google Scholar
• Al-Nasser IA. Salicylate-induced kidney mitochondrial permeability transition is prevented by cyclosporin A. Toxicol Lett 1999;105:1-8
   PubMed Web of Science ®Google Scholar
• Norman C, Howell KA, Millar AH, et al. Salicylic acid is an uncoupler and inhibitor of mitochondrial electron transport. Plant Physiol 2004;134:492-501
   PubMed Web of Science ®Google Scholar
• Lemberg A, Fernández MA, Coll C, et al. Reyes’s syndrome, encephalopathy, hyperammonemia and acetyl salicylic acid ingestion in a city hospital of Buenos Aires, Argentina. Curr Drug Saf 2009;4:17-21
   PubMedGoogle Scholar
• Tai YK, Cheong YM, Almsherqi ZA, et al. High dose clopidogrel decreases mice liver mitochondrial respiration function in vitro. Int J Cardiol 2009;133:250-2
   PubMed Web of Science ®Google Scholar
• Zahno A, Bouitbir J, Maseneni S, et al. Hepatocellular toxicity of clopidogrel: mechanisms and risk factors. Free Radic Biol Med 2013;65:208-16
   PubMed Web of Science ®Google Scholar
• Maseneni S, Donzelli M, Brecht K, et al. Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes. Toxicology 2013;308:11-19
   PubMed Web of Science ®Google Scholar
• Torraco A, Carrozzo R, Piemonte F, et al. Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial. Biochimie 2014;102:166-73
   PubMed Web of Science ®Google Scholar
• Koliesnikova IeE, Nosar VI, Bratus LV. Pharmacological correction of experimental mitochondrial dysfunction of brain stem neurons by rhytmocor and mildronate. Fiziol Zh 2013;59:58-64
   PubMedGoogle Scholar
• Tsutsumi Y, Oshita S, Kawano T, et al. Lidocaine and mexiletine inhibit mitochondrial oxidation in rat ventricular myocytes. Anesthesiology 2001;95:766-70
   PubMed Web of Science ®Google Scholar
• Kaptanoglu E, Caner H, Solaroglu I, et al. Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury. J Neurosurg Spine 2005;3:53-6
   PubMed Web of Science ®Google Scholar
• Qiang G, Zhang L, Yang X, et al. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. Eur J Pharmacol 2012;685:156-64
   PubMed Web of Science ®Google Scholar
• Wakai T, Yoshioka H, Yagi T, et al. Effects of valsartan on neuroprotection and neurogenesis after ischemia. Neuroreport 2011;22:385-90
   PubMed Web of Science ®Google Scholar